Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Phenomenome Discoveries Inc.
DescriptionProdrug of a naturally occurring peripheral ethanolamine plasmalogen (PEP) precursor that restores PEPs and enhances cholinergic neuron function and choline high affinity transport
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat and prevent Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today